(IN BRIEF) The Institute of Cancer Research has led a study showing that chromosomal instability in circulating tumour cells can predict resistance to cabazitaxel in men with advanced prostate cancer. Using blood samples from more than 200 patients enrolled in … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Blood test developed by ICR researchers may guide treatment decisions in advanced prostate cancer, cabazitaxel, CARD trial, chemotherapy resistance, chromosomal instability, circulating tumour cells, JCI Insight, liquid biopsy, mCRPC, metastatic castration-resistant prostate cancer, oncology biomarkers, personalised cancer treatment, Prostate Cancer Research, Sanofi, The Institute of Cancer Research London
(IN BRIEF) UK researchers have developed a pioneering blood test using Fourier Transform Infrared microspectroscopy that can detect a single lung cancer cell circulating in the bloodstream. The technique analyses the unique chemical fingerprint of cancer cells, offering a simpler, … Read the full press release
Posted in Business, Education, Financial, Industrial, Investment, Management, News, Sports, United Kingdom
Tagged blood test, Breakthrough FT IR Technique Could Transform Early Lung Cancer Detection, Cancer Detection, cancer monitoring, circulating tumour cells, early diagnosis, FT IR microspectroscopy, infrared spectroscopy, Josep Sulé Suso, Keele University, liquid biopsy, Loughborough University, lung cancer, NHS cancer care, oncology research, Paul Roach, University Hospitals of North Midlands NHS Trust
(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million loan agreement with Universal DX, a Spanish startup pioneering blood-based liquid biopsy solutions for early cancer detection. The investment will accelerate the development and commercialization of their colorectal, … Read the full press release
(IN BRIEF) Amadix, a Spanish biotech company focused on non-invasive blood tests for early cancer detection, has secured a €15 million loan from the European Investment Bank (EIB). This funding, backed by InvestEU, will support Amadix in advancing its blood … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Spain, Technology
Tagged AI, Amadix, artificial intelligence, colorectal cancer, DiagnoLung, digitalization, early cancer detection, Early Detection, EIB, EU Beating Cancer Plan, European Investment Bank, European medtech startups, InvestEU, life sciences, liquid biopsy, miRNAs, non-invasive blood tests, PancreaDix, partnership, PreveCol, protein analysis, Rocío Arroyo, sustainability, technological innovation, U.S. market, Valladolid, €15 million loan
New test featured today in Gut, a leading international journal published by BMJ, uses A.I. to accurately predict the stages of the whole spectrum of liver diseases, from NAFLD to NASH and liver fibrosis (PRESS RELEASE) BOSTON, MA, United States, … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Technology
Tagged A.I., blood test, BMJ, cirrhosis, diagnosis, Frank Jaksch, gastroenterology journal, gut, HEPAR-QTM, hepatology journal, King’s College London, liquid biopsy, liquid biopsy test, liver biopsy, liver cancer, liver diseases, liver fibrosis, metabolic diseases diagnostics, Metadeq, NAFLD, NASH, NASH Diagnosis Problem, non-alcoholic fatty liver disease, Non-alcoholic steato-hepatitis, Non-Invasive Blood Test, novel protein biomarkers, PLIN2, predictive algorithm, Professor Geltrude Mingrone, RAB14, SDDPR, Stacey Doss
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?